###begin article-title 0
Urocortin in Second Trimester Amniotic Fluid: Its Role as Predictor of Preterm Labor
###end article-title 0
###begin p 1
Recommended by Philipp M. Lepper
###end p 1
###begin p 2
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Backgound</italic>
###xml 514 520 514 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Method</italic>
###xml 800 807 800 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results</italic>
###xml 1157 1158 1153 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1233 1243 1229 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conclusion</italic>
###xml 199 204 <span type="species:ncbi:9606">human</span>
###xml 314 319 <span type="species:ncbi:9606">human</span>
###xml 857 862 <span type="species:ncbi:9606">women</span>
###xml 922 927 <span type="species:ncbi:9606">women</span>
###xml 1081 1086 <span type="species:ncbi:9606">women</span>
###xml 1168 1173 <span type="species:ncbi:9606">women</span>
Backgound. The existence of a "placental clock" which determines the duration of gestation has been previously proposed. It is related to placental CRH secretion and is active from an early phase in human pregnancy. Urocortin is a specific ligand for the corticotropin-releasing factor (CRF) receptor expressed by human trophoblast and fetal membranes. The purpose of this study was to evaluate whether urocortin concentrations in the early second trimester amniotic fluid might serve to predict preterm delivery. Method. The urocortin concentrations in early second trimester amniotic fluid were measured in 41 pregnancies with term delivery and in 41 pregnancies with preterm delivery by using an immunoradiometric assay. Conditional logistic regression analysis was used for statistical analysis. Results. Mean amniotic fluid urocortin concentrations in women with preterm labor were 1.55 +/- 0.63 ng/mL while those in women with term labor were 1.6 +/- 0.49 ng/mL (p: NS). No statistical significant results were found when comparing amniotic fluid urocortin concentrations in women with preterm premature rupture of membranes leading to preterm labor (n = 19) to women with term delivery without premature rupture of membranes. Conclusion. These results suggest that urocortin concentrations in the amniotic fluid of genetic amniocentesis are not predictive of preterm labor and birth.
###end p 2
###begin title 3
1. Introduction
###end title 3
###begin p 4
###xml 52 53 52 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 405 410 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 444 445 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">3</xref>
###xml 446 447 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">5</xref>
###xml 625 626 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">6</xref>
###xml 789 790 785 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">7</xref>
Preterm labor affecting 10%-15% of all pregnancies [1] is responsible for increased perinatal mortality and morbidity, particularly for cerebral palsy [2]. Although various obstetric, anatomic, or medical risk factors are associated with preterm labor, 50% of such cases are idiopathic. An inflammatory process was proposed by many authors. Thus, increased amniotic fluid levels of cytokines as IL-6, TNF-alpha, IL1-ra, IL-8, ADAM-8, and ITAC [3-5] were determined and were considered to serve as predictors of preterm labor. However, other investigators suggest the "placental clock" model in the prediction of labor onset [6]. Thus, it was proposed that fetal or maternal stress might play a significant role in initiating the cascade of intracellular signals leading to preterm labour [7].
###end p 4
###begin p 5
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">8</xref>
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">9</xref>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">10</xref>
###xml 253 254 253 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">9</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">11</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">13</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">14</xref>
###xml 239 242 <span type="species:ncbi:10116">rat</span>
Corticotropin releasing factor (CRF) family comprises a variety of neuropeptides, CRF, and urocortin 1-3 [8]. Vaughan et al. [9] were the first to identify urocortin-a 40-amino-acid peptide which exhibits a 45% homology to CRF [10]-in the rat midbrain [9]. Urocortin is produced in the syncytiotrophoblast, deciduas, and fetal membranes [11-13]. Furthermore, Florio et al. stressed the important role of the fetus as a source of urocortin during labour [14].
###end p 5
###begin p 6
###xml 33 35 33 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">15</xref>
###xml 37 39 37 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">16</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">16</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">18</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">17</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">18</xref>
Urocortins act on CRF receptors [15, 16]. More specifically, CRF-receptor-1 binds CRF and urocortin with similar affinity, whereas CRF-receptor-2 binds urocortin with a 40-fold higher affinity than CRF [16-18]. Both these neuropeptides bind to the receptors and act by activating G-protein-coupled signal transduction and cAMP production [17, 18]. 
###end p 6
###begin p 7
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">19</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">26</xref>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">22</xref>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">7</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">11</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">24</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">27</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">28</xref>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">20</xref>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">26</xref>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">19</xref>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">23</xref>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">25</xref>
###xml 978 983 <span type="species:ncbi:9606">women</span>
###xml 1121 1126 <span type="species:ncbi:9606">women</span>
Urocortin is characterized by specific properties which are implicated in the initiation of labor. Previous studies described that urocortins could increase myometrial contractility in an autocrine and paracrine manner through CRF-receptors-2 [19-26]. They could act directly [22] or indirectly through prostaglandins, estradiol, or ACTH secretion [7, 11, 24, 27, 28] on the myometrial cells. Sirianni et al. also pointed on the role of urocortin in triggering adrenal secretion of steroids relevant to parturition [20]. Moreover, urocortin elevates MMP-9 levels which lead to matrix disorganization and rupture of membranes [26]. Also, they regulate placental blood flow through the NO/cGMP pathway [19, 23]. Furthermore, a role of urocortin in the regulation of fetal adrenal function is also proposed [25]. Taken into account the properties of urocortin, we hypothesized that increased levels of amniotic fluid urocortin might predict, even from an early stage of pregnancy, women prone to deliver at term. Therefore, we aimed to determine urocortin levels in amniotic fluid, acquired during genetic amniocentesis, in women who delivered preterm as compared to those delivering at term and its possible influence on preterm premature rupture of membranes. To our knowledge, this is the first study to examine this issue.
###end p 7
###begin title 8
2. Method
###end title 8
###begin p 9
###xml 327 332 <span type="species:ncbi:9606">women</span>
###xml 401 406 <span type="species:ncbi:9606">Women</span>
###xml 433 438 <span type="species:ncbi:9606">women</span>
A prospective cohort study was performed in collaboration of the Second Department of Obstetrics and Gynecology, University of Athens, Aretaieion Hospital, and the Department of Fetal Medicine of "LITO" Maternity Hospital, Athens, Greece, during the period September 2005-December 2006. The study population consisted of Greek women with singleton pregnancies who presented for genetic amniocentesis. Women with twin pregnancies and women with known history of uterine abnormalities, cone biopsy, significant vaginal bleeding, and fetal malformations were excluded from the study.
###end p 9
###begin p 10
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">29</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">32</xref>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">33</xref>
###xml 695 713 <span type="species:ncbi:2098">Mycoplasma hominis</span>
###xml 718 739 <span type="species:ncbi:813">Chlamydia trachomatis</span>
###xml 854 868 <span type="species:ncbi:1280">Staphylococcus</span>
###xml 923 931 <span type="species:ncbi:9606">patients</span>
###xml 1189 1194 <span type="species:ncbi:9606">woman</span>
Preterm labor was defined as labor before 37 weeks of gestation with regular uterine contractions (at least two uterine contractions/10 minutes during 30 minutes) in combination with the characteristic cervical changes [29-32]. Preterm premature rupture of the fetal membranes was defined as the rupture of the amniotic membranes with release of the amniotic fluid more than one hour before the onset of preterm labor (before 37 weeks of gestation) [33]. Gestational age was calculated from the last menstruation and was confirmed during routine ultrasound in the second trimester (16-19 weeks of gestation). Microbial invasion of the amniotic fluid was defined in our study as positive PCR for Mycoplasma hominis and Chlamydia trachomatis and/or growth of any bacteria (aerobic or anaerobic) in the amniotic fluid cultures except for coagulase-negative Staphylococcus, which was considered to be a skin contamination. All patients were followed until delivery for the occurrence of pregnancy complications. An independent investigator kept the medical records and entered maternal and perinatal data into a database. The ethics committee of our teaching hospital approved the study. Each woman gave informed consent before enrolment in the study and completed a questionnaire including questions regarding personal data, personal history, and family history.
###end p 10
###begin p 11
###xml 116 121 <span type="species:ncbi:9606">women</span>
###xml 416 421 <span type="species:ncbi:9606">woman</span>
###xml 728 746 <span type="species:ncbi:2098">Mycoplasma hominis</span>
###xml 754 775 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Ultrasound-guided transabdominal amniocentesis with a 21-gauge needle was performed under aseptic conditions in 362 women during genetic amniocentesis. Amniocentesis was performed for advanced maternal age and/or increased risk for aneuploidy during nuchal translucency ultrasound. The first 0.5 mL of amniotic fluid was discarded to avoid maternal contamination. Twenty mL of amniotic fluid was aspirated from each woman (15 mL were used for genetic diagnosis). One mL of the uncentrifuged amniotic fluid was then immediately transported to the microbiological laboratory and was cultured for aerobic and anaerobic bacteria. Another 1 mL of the uncentrifuged amniotic fluid was also tested by polymerase chain reaction-PCR for Mycoplasma hominis and/or Chlamydia trachomatis detection. The remaining 3 mL of amniotic fluid were immediately placed in a refridgerator (+4degreesC) and were centrifuged within the next 6 hours at 3000 g and +4degreesC for 10 minutes. The supernatant was stored in polypropylene tubes at -80degreesC until analysis in order to avoid urocortin degradation.
###end p 11
###begin p 12
###xml 786 788 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">34</xref>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">35</xref>
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 551 556 <span type="species:ncbi:9606">Human</span>
###xml 606 611 <span type="species:ncbi:9606">human</span>
###xml 681 686 <span type="species:ncbi:9606">human</span>
###xml 868 873 <span type="species:ncbi:9606">women</span>
Amniotic fluid urocortin levels were determined with an enzyme-linked immunosorbent assay (ELISA) (Urocortin (human), EIA Phoenix Pharmaceuticals INC (Burlingame, California, 94010)) which could measure urocortin in all biological fluids as long as its concentrations are above the kits detection limit. The amniotic fluid samples ran in duplicates. The intra- and interassay coefficients of variation CV% were <5% and <14%, respectively. The detection limit was 0.2 ng/mL with a linear range 0.2-3.8 ng/mL. It should be mentioned that the urocortin (Human) EIA Kit (Catalog No. EK-019-14) is specific for human Urocortin (100% cross reactivity) and shows 0% cross reactivity with human CRF, urocortin 2 or 3, and other substances (cortistatin 14, MCH, LH-RH, NPY, or somatostatin-28) [34, 35]. Laboratory personnel was blinded to the clinical history of the involved women.
###end p 12
###begin p 13
###xml 69 70 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 164 165 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 543 544 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 0 5 <span type="species:ncbi:9606">Women</span>
###xml 101 106 <span type="species:ncbi:9606">woman</span>
###xml 368 373 <span type="species:ncbi:9606">women</span>
###xml 474 479 <span type="species:ncbi:9606">woman</span>
Women who gave a spontaneous preterm delivery were defined as cases (N = 41) while, for each case, a woman matched for age with normal pregnancy served as control (N = 41). Furthermore, subgroup analysis was conducted in order to examine any possible association of urocortin levels with the incidence of preterm delivery with premature rupture of membranes. Nineteen women with preterm labor and premature rupture of membranes were defined as cases, while for every case a woman matched for maternal age delivering at term served as control (N1 = 19). Cases and controls delivered either spontaneously or by caesarean section.
###end p 13
###begin p 14
###xml 167 168 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 329 330 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 619 620 619 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
All data except for age, gestational age at delivery, and gestational age at amniocentesis followed normal distribution (Kolmogorov-Smirnov test). Independent samples t-test was applied to detect differences between groups where continuous variables were normally distributed (urocortin and birthweight). Otherwise, Mann-Whitney U-test was applied. Pearson's Chi square test was used to detect differences between categorical variables. Conditional logistic regression analysis was used to examine the possible associations of urocortin with preterm labor. STATA 8.2 and SPSS 11.5 edition were used for the analysis. A P-value of <.05 was considered to be statistically significant.
###end p 14
###begin title 15
3. Results
###end title 15
###begin p 16
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">36</xref>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">40</xref>
###xml 20 25 <span type="species:ncbi:9606">women</span>
###xml 120 125 <span type="species:ncbi:9606">women</span>
###xml 439 444 <span type="species:ncbi:9606">women</span>
###xml 474 481 <span type="species:ncbi:9606">infants</span>
###xml 668 673 <span type="species:ncbi:9606">women</span>
Out of 362 pregnant women who were included in the study, 41 had preterm labor (incidence: 11.26%) and a subgroup of 19 women delivered preterm with premature rupture of membranes (incidence: 5.22%). Ten were excluded after amniocentesis in the presence of fetal chromosomal abnormalities (two with trisomy 18, two with trisomy 21, one with Turner syndrome, one with Klinefelter syndrome, and other four with less usual karyotypes). Eight women were lost to follow-up. Four infants were delivered by caesarean section before the onset of labor for maternal (severe preeclampsia) or fetal reasons (compromised fetal growth or umbilical Doppler flow abnormalities). Two women delivered within 30 days following amniocentesis and were excluded from the study, as their delivery was considered related to the procedure of amniocentesis [36-40].
###end p 16
###begin p 17
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">1 </xref>
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">2</xref>
###xml 346 364 <span type="species:ncbi:2098">Mycoplasma hominis</span>
###xml 462 467 <span type="species:ncbi:9606">women</span>
###xml 503 508 <span type="species:ncbi:9606">women</span>
The demographic data of the study population are presented in Tables 1 and 2. No statistical significant differences concerning mean maternal age, gestational age at amniotic fluid sampling, indication for amniocentesis, and incidence of nulliparity were shown between the groups. Amniotic fluid cultures for common bacteria were negative, while Mycoplasma hominis and Chlamydia were identified in 2/338 and 2/338 subjects, respectively. However, one of the two women with Mycoplasma and one of the two women with Chlamydia delivered preterm.
###end p 17
###begin p 18
###xml 471 482 467 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1(a)</xref>
###xml 803 814 795 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1(b)</xref>
###xml 333 338 <span type="species:ncbi:9606">women</span>
###xml 396 401 <span type="species:ncbi:9606">women</span>
###xml 675 680 <span type="species:ncbi:9606">women</span>
###xml 741 746 <span type="species:ncbi:9606">women</span>
Logistic regression analysis did not show any significant associations between urocortin levels and preterm delivery. Furthermore, no significant association between urocortin concentrations and the time interval between amniotic fluid sampling and delivery was observed. More specifically, the amniotic fluid levels of urocortin in women with preterm labor were not significantly higher than in women delivering at term (1.55 +/- 0.63 ng/mL versus 1.52 +/- 0.43 ng/mL) (Figure 1(a)). Moreover, no significant association was found between urocortin levels and preterm delivery with premature rupture of membranes. More specifically the amniotic fluid levels of urocortin in women with premature rupture of membranes were not higher than in women at term (1.64 +/- 0.54 ng/mL versus 1.6 +/- 0.49 ng/mL (Figure 1(b)).
###end p 18
###begin title 19
4. Discussion
###end title 19
###begin p 20
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">11</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">41</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">42</xref>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">42</xref>
###xml 1064 1066 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">41</xref>
###xml 1068 1070 1068 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">43</xref>
###xml 1203 1205 1203 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">42</xref>
###xml 1207 1209 1207 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">44</xref>
###xml 154 159 <span type="species:ncbi:9606">women</span>
###xml 1165 1170 <span type="species:ncbi:9606">human</span>
This is the first study which examined an association between amniotic fluid urocortin levels and possible prediction of preterm labor among asymptomatic women during the second trimester of pregnancy. The gene expression and localization of urocortin in syncytiotrophoblast, cytotrophoblast, and deciduas by using in situ hybridization and immunohistochemistry were reported in a study [11]. Also, other investigators showed that immunoreactive urocortin was detectable in maternal plasma from seven weeks of gestation and that such concentrations did not change as gestation progressed [41]. In another study, it was found that fetal plasma urocortin levels measured in umbilical cord artery and vein were increased in term and preterm labors [42]. Moreover, in the same study, it was revealed that maternal and fetal plasma urocortin levels increase at term or preterm vaginal labor compared to those after elective caesarean section [42]. It is known that the levels of CRF in maternal plasma increase throughout pregnancy, whereas urocortin remains constant [41, 43]. For this reason, many investigators proposed that urocortin might play an important role in human parturition and onset of labor [42, 44].
###end p 20
###begin p 21
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">27</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">14</xref>
###xml 526 527 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">7</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">27</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">28</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">28</xref>
###xml 1002 1004 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">21</xref>
###xml 1179 1181 1179 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">21</xref>
###xml 1146 1151 <span type="species:ncbi:9606">human</span>
It has been stated that CRH and urocortin 1 appear to be predictors of the duration of gestation [27]. This could be explained by the fact that CRH through its receptors protects gestation by promoting myometrial quiescence via the generation of cAMP and cGMP and by upregulating nitric oxide synthase expression [14]. As proposed, urocortin has a significant role in uterine contractility in vitro by indirectly triggering a myometrial response through stimulation of placental adrenocorticotropin and prostaglandin release [7, 27]. Some investigators showed a distinctive role of CRF-receptors-2 in the control of uterine contractility during pregnancy [28]. Moreover, they suggested that urocortin 2 could have a dual role during pregnancy and labor: firstly, in the maintenance of myometrial relaxation and secondly, in the stimulation of contractility [28]. Other investigators trying to explain the possible mechanisms of myometrial stimulation found that CRH-induced activation is insufficient [21]. On the other hand, urocortin 1 could act through its receptors and could stimulate myometrial mitogen-activated protein kinase in cultured human pregnant myometrial cells [21].
###end p 21
###begin p 22
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">20</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">20</xref>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">20</xref>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">21</xref>
###xml 1018 1020 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">19</xref>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">21</xref>
###xml 1025 1027 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">25</xref>
###xml 1296 1298 1296 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">19</xref>
###xml 1300 1302 1300 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">21</xref>
###xml 1303 1305 1303 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">25</xref>
###xml 1531 1533 1531 1533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">26</xref>
###xml 606 612 <span type="species:ncbi:9606">humans</span>
In explaining preterm labor, the mechanism of the urocortin-activated placental, maternal, and fetal hypothalamo-pituitary-adrenal axis, as a response to stress, has been also implicated [20]. In this respect, urocortin has been used to test this theory. Thus, it has been proposed that ACTH, CRH, and urocortin 1 stimulate the fetal adrenal near term by increasing the production of cortisol and dehydroepiandrosterone sulfate and by activating CRF-receptor-1 [20]. The elevation in dehydroepiandrosterone sulfate levels could be used for placental estrogen synthesis, a fact that leads to parturition in humans [20]. At term, uterine contractility is proposed to be enhanced by upregulation of oxytocin receptor expression and communication between oxytocin and CRH receptors [21]. CRH/urocortins have a dual role: on the one hand by acting via their receptors and on the other by activating G-protein-coupled signal transduction and potentially by enhancing the oxytocin-driven generation of inositol triphosphate [19, 21-25]. Moreover, they generate-via their receptors-prostaglandins from the fetal membranes and deciduas; they play a role in placental vasodilation and they participate in fetal adrenal function and organ maturation in order to protect the fetus from environmental stress [19, 21-25]. Urocortin was also shown to induce a degradation of extracellular matrix by secretion of matrix-metalloproteinase-9 (MMP-9) with no changes in tissue inhibitors of MMP-1 (TIMP-1), a process leading to rupture of membranes [26].
###end p 22
###begin p 23
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">45</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">45</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">45</xref>
###xml 111 116 <span type="species:ncbi:9606">women</span>
###xml 214 219 <span type="species:ncbi:9606">women</span>
###xml 631 636 <span type="species:ncbi:9606">women</span>
###xml 858 866 <span type="species:ncbi:9606">patients</span>
###xml 1469 1474 <span type="species:ncbi:9606">human</span>
Recent studies used maternal plasma urocortin between 28 and 34 weeks gestation to predict preterm delivery in women with threatened preterm labor [45]. They found that plasma urocortin was significantly higher in women who delivered preterm versus those delivering at term [45]. Based on the above findings, we investigated whether amniotic fluid urocortin levels during genetic amniocentesis could serve as a new marker predicting preterm labor. However, no statistically significant association was found neither in the group of preterm labor nor in the group of premature rupture of membranes group when compared with group of women delivering at term. In contrast to Florio et al. [45], we studied amniotic fluid urocortin levels at an earlier time point (second trimester) and in a different fluid (amniotic fluid versus maternal plasma). Furthermore, patients in the abovementioned study presented a threatened labor. It is noteworthy that our preterm delivery rate of 11.3 % occurred in a general and nonhigh-risk obstetric population who underwent amniocentesis for elevated maternal age or high nuchal translucency. Although our study did not find a predictive role of urocortin, the elevation of its levels with advancing gestation cannot be excluded. In conclusion, the present study did not find an association between urocortin levels in the second trimester and preterm delivery. Further studies are needed to elucidate the possible role of urocortin in human parturition.
###end p 23
###begin article-title 24
Prevention of premature birth
###end article-title 24
###begin article-title 25
###xml 26 33 <span type="species:ncbi:9606">infants</span>
Cerebral palsy in preterm infants: a population-based case-control study of antenatal and intrapartal risk factors
###end article-title 25
###begin article-title 26
Elevated mid-trimester amniotic fluid ADAM-8 concentrations as a potential risk factor for preterm delivery
###end article-title 26
###begin article-title 27
###xml 52 57 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 75 80 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
Elevated second trimester amniotic fluid interferon gamma-inducible T-cell alpha chemoattractant concentrations as a possible predictor of preterm birth
###end article-title 27
###begin article-title 28
Intrauterine infection and preterm delivery
###end article-title 28
###begin article-title 29
###xml 44 49 <span type="species:ncbi:9606">human</span>
A placental clock controlling the length of human pregnancy
###end article-title 29
###begin article-title 30
###xml 31 36 <span type="species:ncbi:9606">human</span>
Role of stress peptides during human pregnancy and labour
###end article-title 30
###begin article-title 31
Urocortins as cardiovascular peptides
###end article-title 31
###begin article-title 32
Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor
###end article-title 32
###begin article-title 33
Molecules in focus: urocortin
###end article-title 33
###begin article-title 34
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 43 48 <span type="species:ncbi:9606">human</span>
Human placenta and fetal membranes express human urocortin mRNA and peptide
###end article-title 34
###begin article-title 35
###xml 33 38 <span type="species:ncbi:9606">human</span>
Characterization of urocortin in human pregnancy
###end article-title 35
###begin article-title 36
Potential uses of corticotropin-releasing hormone antagonists
###end article-title 36
###begin article-title 37
###xml 14 19 <span type="species:ncbi:9606">human</span>
Urocortins in human reproduction
###end article-title 37
###begin article-title 38
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor
###end article-title 38
###begin article-title 39
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor
###end article-title 39
###begin article-title 40
###xml 110 113 <span type="species:ncbi:10116">rat</span>
Cloning and characterization of a functionally distinct corticotropin- releasing factor receptor subtype from rat brain
###end article-title 40
###begin article-title 41
Corticotropin-releasing hormone receptor (CRHR)1 and CRHR2 are both trafficking and signaling receptors for urocortin
###end article-title 41
###begin article-title 42
###xml 61 66 <span type="species:ncbi:9606">human</span>
Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro
###end article-title 42
###begin article-title 43
###xml 143 148 <span type="species:ncbi:9606">human</span>
Corticotropin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells
###end article-title 43
###begin article-title 44
###xml 136 141 <span type="species:ncbi:9606">human</span>
Urocortin, but Not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1a and R2b CRH receptor subtypes and stimulation of Gq-proteins
###end article-title 44
###begin article-title 45
Role of corticotropin-releasing hormone in onset of labour
###end article-title 45
###begin article-title 46
###xml 62 67 <span type="species:ncbi:9606">human</span>
Corticotropin-releasing hormone-induced vasodilatation in the human fetal- placental circulation: involvement of the nitric oxide-cyclic guanosine 3',5'-monophosphate-mediated pathway
###end article-title 46
###begin article-title 47
###xml 84 89 <span type="species:ncbi:9606">human</span>
Local stimulation of prostaglandin production by corticotropin-releasing hormone in human fetal membranes and placenta
###end article-title 47
###begin article-title 48
###xml 82 87 <span type="species:ncbi:9606">human</span>
Expression and coupling characteristics of the CRH and orexin type 2 receptors in human fetal adrenals
###end article-title 48
###begin article-title 49
###xml 169 174 <span type="species:ncbi:9606">human</span>
Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes
###end article-title 49
###begin article-title 50
Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro
###end article-title 50
###begin article-title 51
###xml 29 34 <span type="species:ncbi:9606">human</span>
Urocortin II Is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the Type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility
###end article-title 51
###begin article-title 52
The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection
###end article-title 52
###begin article-title 53
Cervical sonography in preterm labor
###end article-title 53
###begin article-title 54
###xml 95 100 <span type="species:ncbi:9606">Child</span>
###xml 112 117 <span type="species:ncbi:9606">Human</span>
The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network
###end article-title 54
###begin article-title 55
###xml 97 102 <span type="species:ncbi:9606">women</span>
Transvaginal sonographic measurement of cervical length to predict preterm birth in asymptomatic women at increased risk: a systematic review
###end article-title 55
###begin article-title 56
An evidence-based approach to the evaluation and treatment of premature rupture of membranes-part I
###end article-title 56
###begin article-title 57
Urocortin in amniotic fluid and Down syndrome
###end article-title 57
###begin article-title 58
High levels of intrauterine corticotropin-releasing hormone, urocortin, tryptase, and interleukin-8 in spontaneous abortions
###end article-title 58
###begin article-title 59
Complications of amniocentesis: a review
###end article-title 59
###begin article-title 60
Midtrimester genetic amniocentesis. A review of the fetal risks
###end article-title 60
###begin article-title 61
###xml 70 75 <span type="species:ncbi:9606">women</span>
Randomised controlled trial of genetic amniocentesis in 4606 low-risk women
###end article-title 61
###begin article-title 62
Pregnancy outcome following genetic amniocentesis at 11-14 versus 16-19 weeks' gestation
###end article-title 62
###begin article-title 63
Genetic amniocentesis: gestation-specific pregnancy outcome and comparison of outcome following early and traditional amniocentesis
###end article-title 63
###begin article-title 64
###xml 54 59 <span type="species:ncbi:9606">human</span>
Localization and characterization of urocortin during human pregnancy
###end article-title 64
###begin article-title 65
High fetal urocortin levels at term and preterm labor
###end article-title 65
###begin article-title 66
###xml 66 71 <span type="species:ncbi:9606">human</span>
Lack of gestation-related changes of urocortin gene expression in human placenta
###end article-title 66
###begin article-title 67
Placental corticotrophin releasing hormone and urocortin-possible role in mechanism of preterm labor
###end article-title 67
###begin article-title 68
Prediction of preterm delivery based on maternal plasma urocortin
###end article-title 68
###begin p 69
###xml 70 75 <span type="species:ncbi:9606">women</span>
###xml 332 337 <span type="species:ncbi:9606">women</span>
###xml 441 446 <span type="species:ncbi:9606">women</span>
(a) Error bars of the concentrations of amniotic fluid urocortin from women with preterm delivery (cases) (Mean +/- SD: 1.55 +/- 0.63 ng/mL) and fullterm delivery (controls) (Mean +/- SD:1.52 +/- 0.43 ng/mL). Each box represents the mean (95% CI) concentration. (b) Error bars of the concentrations of amniotic fluid urocortin from women with preterm delivery and premature rupture of membranes (cases) (Mean +/- SD:1.64 +/- 0.54 ng/mL) and women with fullterm delivery (controls) (Mean +/- SD: 1.6 +/- 0.49 ng/mL). Each box represents the mean (95% CI) concentration.
###end p 69
###begin p 70
###xml 40 41 40 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 67 68 67 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 20 25 <span type="species:ncbi:9606">women</span>
Demographic data of women with preterm (N = 41) and term delivery (N = 41).
###end p 70
###begin p 71
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 20 25 <span type="species:ncbi:9606">women</span>
###xml 93 98 <span type="species:ncbi:9606">women</span>
Demographic data of women with preterm labor and premature rupture of membranes (N = 19) and women delivering at term (N = 19).
###end p 71

